Withdrawal Statement
This version of the manuscript and associated files have been removed owing to concerns of data privacy. The paper has been published and is available at doi:10.1111/add.16630.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Posted April 01, 2024.
WITHDRAWN: Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients
